Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Multi-antigen CMV-modified vaccinia Ankara vaccine |
Trade Name | |
Synonyms | CMV-MVA Triplex Vaccine|CMV-Modified Vaccinia Ankara Vaccine |
Drug Descriptions |
Multi-antigen CMV-modified vaccinia Ankara vaccine is viral-based vaccine engineered to express three cytomegalovirus (CMV) antigens, which may induce a CMV-specific immune response (PMID: 27760761, PMID: 35272066). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C111036 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CMV-CD19 CAR T-cells + Multi-antigen CMV-modified vaccinia Ankara vaccine | CMV-CD19 CAR T-cells Multi-antigen CMV-modified vaccinia Ankara vaccine | 0 | 1 |
Multi-antigen CMV-modified vaccinia Ankara vaccine | Multi-antigen CMV-modified vaccinia Ankara vaccine | 0 | 0 |